Colorectal cancer treatment in elderly patients: An update on recent clinical studies

Clinical Colorectal Cancer

Volumn 7, Issue 6, 2008, Pages 357-363

  Merlin, Federica ^a   Prochilo, Tiziana ^a   Tondulli, Luca ^a   Kildani, Basem ^a   Beretta, Giordano Domenico ^a  

^a S Orsola Hospital   (Italy)

Author keywords

Adjuvant metastatic chemotherapy; FOLFOX; Quality of life; Rectal cancer

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PANITUMUMAB; UFT;

ADVERSE OUTCOME; ANEMIA; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL STUDY; CLINICAL TRIAL; COLON CANCER; COLORECTAL CANCER; CONTINUOUS INFUSION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL TOXICITY; GERIATRIC PATIENT; GROUPS BY AGE; HUMAN; LIVER METASTASIS; LIVER TOXICITY; LOW DRUG DOSE; MEDICAL INFORMATION; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; NAUSEA AND VOMITING; NEUROLOGICAL COMPLICATION; NEUROPATHY; PALLIATIVE THERAPY; POPULATION RESEARCH; RASH; RECTUM CANCER; REVIEW; SYSTEMIC THERAPY; THROMBOEMBOLISM; TOXICITY; UNSPECIFIED SIDE EFFECT;

EID: 58849098184     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2008.n.047     Document Type: Review

References (58)

1. Faivre J, Lemmens VE, Quipourt V, et al. Management and survival of colorectal cancer in the elderly in population-based studies. Eur J Cancer 2007; 43:2279-84.
2. Balducci L. The geriatric cancer patient: equal benefit from equal treatment. Cancer Control 2001; 8(2 suppl):1-25.
3. Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002; 20:494-502.
4. Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 2005; 104:1998-2005.
5. Colorectal Cancer Collaborative Group. Surgery for colorectal cancer in elderly patients: a systematic review. Lancet 2000; 356:968-74.
6. Bouvier AM, Launoy G, Lepage C, et al. Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther 2005; 22:233-41.
7. J. Rodón, M. Garcia, J. Perez, et al. Adjuvant treatment in Stage III colon cancer: Comparison of patients recruited into trials and those treated outside a clinical trial: analysis of recruitment, trial effect and inclusion of elderly patients. J Clin Oncol 2005; 23(16 suppl):557s (Abstract 6118).
8. Janssen-Heijnen ML, Houterman S, Lemmens VE, et al. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 2005; 55:231-40.
9. Schrag D, Cramer LD, Bach PB, et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001; 93:850-7.
10. Sargent DJ, Goldberg RM, Jacobson SD, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001; 345:1091-7.
11. Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol. 2002; 20:3992-8.
12. Sundararajan V, Mitra N, Jacobson JS, et al. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med 2002; 136:349-57.
13. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 2003; 21:1293-300.
14. Lonardi S, Stefani M, Jirillo A, et al. Benefit of fluorouracil and folinic acid adjuvant in colon cancer elderly patients J Clin Oncol 2006; 24(18 suppl):621s (Abstract 13564).
15. Sargent DJ, Goldberg RM, Bleiberg H, et al. A pooled safety and efficacy analysis of the FOLFOX4 regimen (bi-monthly oxaliplatin plus fluorouracil/leucovorin) in elderly compared to younger patients with colorectal cancer. J Clin Oncol 2006; 24(18 suppl):150s (Abstract 3517).
16. Diaz-Rubio E, Burris H, Douillard JK, et al. Safety of capecitabine (X) compared to fluorouracil/leucovorin (5-FU/LV) for the adjuvant treatment of elderly colon cancer patients (pts). Proc Amer Soc Clin Oncol 2004; 22:(Abstract 3737).
17. Jensen SA, Vilmar A, Sørensen JB. Adjuvant chemotherapy in elderly patients (>or=75 yr) completely resected for colon cancer stage III compared to younger patients: toxicity and prognosis. Med Oncol 2006; 23:521-31.
18. Neugut AI, Matasar M, Wang X, et al. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol 2006; 24:2368-75.
19. Jessup JM, Stewart A, Greene FL, et al. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 2005; 294:2703-11.
20. Magne N, Francois E, Broisin L, et al. Palliative 5-fluorouracil-based chemotherapy for advanced colorectal cancer in the elderly: results of a 10-year experience. Am J Clin Oncol 2002; 25:126-30.
21. Ho, O'Reilly, Ng K, et al. Population-based analysis of patients with advanced colorectal cancer: The impact of age on treatment and outcomes. J Clin Oncol 2005 23(16 suppl):274s (Abstract 3614).
22. D'Andre S, Sargent DJ, Cha SS, et al. 5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a North Central Cancer Treatment Group study. Clin Colorectal Cancer 2005; 4:325-31.
23. Folprecht G, Cunningham D, Ross P, et al. Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Ann Oncol 2004; 15:1330-8.
24. Daniele B, Rosati G, Tambaro R, et al. First-line chemotherapy with fluorouracil and folinic acid for advanced colorectal cancer in elderly patients: a phase II study. J Clin Gastroenterol 2003; 36:228-33.
25. Feliu J, Escudero P, Llosa F, et al. Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study. J Clin Oncol 2005; 23:3104-11.
26. Cripps MC, Vincent M, Jonker D, et al. Dose reduced first-line capecitabine monotherapy in older and less fit patients with advanced colorectal cancer (ACRC). J Clin Oncol 2005; 23(16 suppl):265s (Abstract 3577).
27. Popa C, Luo W, Hochster H, et al. A phase II study of orzel (UFT+leucovorin) in elderly ( 75 years old) patients with colorectal cancer: Results of ECOG 1299. J Clin Oncol 2005 23(16 suppl):273s (Abstract 3608).
28. Goldberg RM, Tabah-Fisch I, Bleiberg H, et al. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol 2006; 24:4085-91.
29. Figer A, Perez-Staub N, Carola E, et al. FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study. Cancer 2007; 110:2666-71.
30. Oh Y, Kim YK, Han SW, et al. Efficacy of reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer (CRC). J Clin Oncol 2005; 23(16 suppl):300s (Abstract 3720).
31. Mattioli R, Massacesi C, Recchia F, et al. High activity and reduced neurotoxicity of bi-fractionated oxaliplatin plus 5-fluorouracil/leucovorin for elderly patients with advanced colorectal cancer. Ann Oncol 2005; 16:1147-51.
32. Feliu J, Salud A, Escudero P, et al. XELOX (capecitabine plus oxaliplatin) as first- line treatment for elderly patients over 70 years of age with advanced colorectal cancer. Br J Cancer 2006; 94:969-75.
33. Comella P, Natale D, Farris A, et al. Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108. Cancer 2005; 104:282-9.
34. Comandone P, Pochettino P, Bergnolo A, et al. Capecitabine and oxaliplatin: A phase II study with a new schedule of administration in elderly patients with advanced colorectal cancer. J Clin Oncol 2005; 23(16 suppl):291s (Abstract 3681).
35. Twelves CJ, Butts CA, Cassidy J, et al. Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study. Clin Colorectal Cancer 2005; 5:101-7.
36. Rosati G, Cordio S, Tucci A, et al. A phase II trial of oxaliplatin (L-OHP) and uracil-tegafur (UFT)/folinic acid (FA) for advanced colorectal cancer (ACC) in elderly patients. Proc Amer Soc Clin Oncol 2004; 22: (Abstract 3681).
37. Seymour MT, Maughan TS, Wasan HS, et al. Capecitabine (Cap) and oxaliplatin (Ox) in elderly and/or frail patients with metastatic colorectal cancer: The FOCUS2 trial. J Clin Oncol 2007; 25(18 suppl):500s (Abstract 9030).
38. Folprecht G, Rougier P, Saltz L, et al. Irinotecan in first line therapy of elderly and non-elderly patients with metastatic colorectal cancer: Meta-analysis of four trials investigating 5-FU and irinotecan. J Clin Oncol 2006; 24(18 suppl):165s (Abstract 3578).
39. Chau I, Norman AR, Cunningham D, et al. Elderly patients with fluoropy- rimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy. Br J Cancer 2004; 91:1453-8.
40. Sastre J, Marcuello E, Masutti B, et al. Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors study. J Clin Oncol 2005; 23:3545-51.
41. Souglakos J, Pallis A, Kakolyris S, et al. Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial. Oncology 2005; 69:384-90.
42. Fiorentini G, Dentico P, Cantore M, et al. Capecitabine (XE) plus Irinotecan (IRI) as second-line treatment (XELIRI) for metastatic colorectal cancer (MCRC) in elderly patients: feasibility and safety results from a Phase II study J Clin Oncol 2005; 23(16 suppl):289s Abstract 3676).
43. Zacharias T, Jaeck D, Oussoultzoglou E, et al. First and repeat resection of colorectal liver metastases in elderly patients. Ann Surg 2004; 240:858-65.
44. Mazzoni G, Tocchi A, Miccini M, et al. Surgical treatment of liver metastases from colorectal cancer in elderly patients. Int J Colorectal Dis 2007; 22:77-83.
45. Gruenberger T, Schuell B, Kornek G, et al. Elderly patients do benefit from oxaliplatin based neoadjuvant chemotherapy in resectable colorectal cancer liver metastases. J Clin Oncol 2005; 23:271s (Abstract 3601).
46. Pasetto M, Falci C, Sinigaglia G et al. How many colorectal cancer (CRC) patients older than 70 years may be safely treated with bevacizumab? J Clin Oncol 2006 24(18 suppl):623s (Abstract 13589).
47. Bouchahda M, Macarulla T, Spano JP, et al. Cetuximab and irinotecan-based chemotherapy as an active and safe treatment option for elderly patients with extensively pre.treated metastatic colorectal cancer. J Clin Oncol 2007; 25(18 suppl):627s (Abstract 14528).
48. Chang GJ, Skibber JM, Feig BW, et al. Are we undertreating rectal cancer in the elderly? An epidemiologic study. Ann Surg 2007; 246:215-21.
49. Barrier A, Ferro L, Houry S, et al. Rectal cancer surgery in patients more than 80 years of age. Am J Surg 2003; 185:54-7.
50. Bufalari A, Giustozzi G, Burattini MF, et al. Rectal cancer surgery in the elderly: a multivariate analysis of outcome risk factors. J Surg Oncol 2006; 93:173-80.
51. Abir F, Alva S, Longo WE. The management of rectal cancer in the elderly. Surg Oncol 2004; 13:223-34.
52. Bohac GC, Hartshorn K, Cheng D. Combined therapy for rectal cancer in the elderly. J Clin Oncol 2007; 25(18 suppl):625s (Abstract 14504).
53. Reddy N, Yu J, Fakih MG. Toxicities and survival among octogenarians and nonagenarians with colorectal cancer treated with chemotherapy or concurrent chemoradiation therapy. Clin Colorectal Cancer 2007; 6:362-6
54. Lorchel F, Peignaux K, Crehange G, et al. Preoperative radiotherapy in elderly patients with rectal cancer. Gastroenterol Clin Biol 2007; 31:436-41.
55. Larsen SG, Wiig JN, Tretli S, et al. Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age. Colorectal Dis 2006; 8:177-85.
56. Pasetto LM, Basso U, Friso ML, et al. Determining therapeutic approaches in the elderly with rectal cancer. Drugs Aging 2007; 24:781-90.
57. Pasetto LM, Friso ML, Pucciarelli S, et al. Rectal cancer neoadjuvant treatment in elderly patients. Anticancer Res 2006; 26:3913-23.
58. Neugut AI, Fleischauer AT, Sundararajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol 2002; 20:2643-50.